Inhibition by lifarizine of intracellular Ca (2+) rises and glutamate exocytosis in depolarized rat cerebrocortical synaptosomes and cultured neurones

被引:6
作者
Budd, DC
May, GR
Nicholls, DG
McCormack, JG
机构
[1] HERIOT WATT UNIV,SYNTEX RES CTR,DEPT PHARMACOL,EDINBURGH EH14 4AP,MIDLOTHIAN,SCOTLAND
[2] UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT PHARMACOL,INST NEUROSCI,DUNDEE DD1 9SY,SCOTLAND
关键词
lifarizine; intracellular Ca2+; glutamate exocytosis; synaptosomes; cultured neurones; depolarization;
D O I
10.1111/j.1476-5381.1996.tb15380.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of lifarizine (RS-87476) on intracellular Ca2+ rises and the release of glutamate from rat cerebrocortical synaptosomes depolarized with 30 mM KCl were investigated by use of entrapped fura 2 and exogenous glutamate dehydrogenase. 2 Prior (1 min) addition of lifarizine decreased 30 mM KCl-induced total glutamate release, with 3 mu M and 10 mu M causing 39% and 72% averaged decreases from controls. The calcium-dependent component of glutamate release (approx. 40% of total) was similarly decreased by 47% and 74%, whereas the calcium-independent component was decreased by only 32% and 43% respectively. 3 In parallel experiments with fura-2-loaded synaptosomes, lifarizine reduced the depolarization-induced increases in intracellular [Ca2+], suggesting that this is the means by which the decreases in induced increases in intracellular [Caglutamate release are brought about. Lifarizine inhibit-id both the plateau and the spike phases of the Ca2+ increases suggesting that, in addition to its known sodium channel blocking properties, it may also inhibit more than one class of calcium channel in the synaptosomes. 4 Lifarizine at 1 mu M and 3 mu M also inhibited the rises in intracellular [Ca2+] in rat cultured cortical neurones depolarized with 60 mM KCl. 5 These effects of lifarizine on intracellular Ca2+ and glutamate exocytosis may contribute to its neuroprotective action.
引用
收藏
页码:162 / 166
页数:5
相关论文
共 34 条
[1]   COMPARATIVE PROTECTIVE EFFECTS OF NICARDIPINE, FLUNARIZINE, LIDOFLAZINE AND NIMODIPINE AGAINST ISCHEMIC-INJURY IN THE HIPPOCAMPUS OF THE MONGOLIAN GERBIL [J].
ALPS, BJ ;
CALDER, C ;
HASS, WK ;
WILSON, AD .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (04) :877-883
[2]   DRUGS ACTING ON CALCIUM CHANNELS - POTENTIAL TREATMENT FOR ISCHEMIC STROKE [J].
ALPS, BJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (03) :199-206
[3]  
ALPS BJ, 1990, P 20 INT C MED ISIM
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   NEUROPROTECTIVE PROPERTIES OF LIFARIZINE COMPARED WITH THOSE OF OTHER AGENTS IN A MOUSE MODEL OF FOCAL CEREBRAL-ISCHEMIA [J].
BROWN, CM ;
CALDER, C ;
LINTON, C ;
SMALL, C ;
KENNY, BA ;
SPEDDING, M ;
PATMORE, L .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (08) :1425-1432
[6]   THE EFFECT OF LIFARIZINE (RS-87476), A NOVEL SODIUM AND CALCIUM-CHANNEL MODULATOR, ON ISCHEMIC DOPAMINE DEPLETION IN THE CORPUS STRIATUM OF THE GERBIL [J].
BROWN, CM ;
CALDER, C ;
ALPS, BJ ;
SPEDDING, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 (01) :175-177
[7]  
BROWN CM, 1995, CNS DRUG REV, V1, P149
[8]  
BUDD DC, 1995, J NEUROCHEM, V65, P615
[10]  
CHOI DW, 1987, J NEUROSCI, V7, P369